We propose a Bayesian variable selection method in the framework of modal regression for heavy-tailed responses. An efficient expectation-maximization algorithm is employed to expedite parameter estimation. A test statistic is constructed to exploit the shape of the model error distribution to effectively separate informative covariates from unimportant ones. Through simulations, we demonstrate and evaluate the efficacy of the proposed method in identifying important covariates in the presence of non-Gaussian model errors. Finally, we apply the proposed method to analyze two datasets arising in genetic and epigenetic studies.

Risk assessment tools in healthcare commonly employ point-based scoring systems that map patients to ordinal risk categories via thresholds. While electronic health record (EHR) data presents opportunities for data-driven optimization of these tools, two fundamental challenges impede standard supervised learning: (1) partial supervision arising from intervention-censored outcomes, where only extreme categories can be reliably labeled, and (2) asymmetric misclassification costs that increase with ordinal distance. We propose a mixed-integer programming (MIP) framework that jointly optimizes scoring weights and category thresholds under these constraints. Our approach handles partial supervision through per-instance feasible label sets, incorporates asymmetric distance-aware objectives, and prevents middle-category collapse via minimum threshold gaps. We further develop a CSO relaxation using softplus losses that preserves the ordinal structure while enabling efficient optimization. The framework supports governance constraints including sign restrictions, sparsity, and minimal modifications to incumbent tools, ensuring practical deployability in clinical workflows.

We propose Fast-MIA (https://github.com/Nikkei/fast-mia), a Python library for efficiently evaluating membership inference attacks (MIA) against Large Language Models (LLMs). MIA against LLMs has emerged as a crucial challenge due to growing concerns over copyright, security, and data privacy, and has attracted increasing research attention. However, the progress of this research is significantly hindered by two main obstacles: (1) the high computational cost of inference in LLMs, and (2) the lack of standardized and maintained implementations of MIA methods, which makes large-scale empirical comparison difficult. To address these challenges, our library provides fast batch inference and includes implementations of representative MIA methods under a unified evaluation framework. This library supports easy implementation of reproducible benchmarks with simple configuration and extensibility. We release Fast-MIA as an open-source (Apache License 2.0) tool to support scalable and transparent research on LLMs.

Accurate symptom-to-disease classification and clinically grounded treatment recommendations remain challenging, particularly in heterogeneous patient settings with high diagnostic risk. Existing large language model (LLM)-based systems often lack medical grounding and fail to quantify uncertainty, resulting in unsafe outputs. We propose CLIN-LLM, a safety-constrained hybrid pipeline that integrates multimodal patient encoding, uncertainty-calibrated disease classification, and retrieval-augmented treatment generation. The framework fine-tunes BioBERT on 1,200 clinical cases from the Symptom2Disease dataset and incorporates Focal Loss with Monte Carlo Dropout to enable confidence-aware predictions from free-text symptoms and structured vitals. Low-certainty cases (18%) are automatically flagged for expert review, ensuring human oversight. For treatment generation, CLIN-LLM employs Biomedical Sentence-BERT to retrieve top-k relevant dialogues from the 260,000-sample MedDialog corpus. The retrieved evidence and patient context are fed into a fine-tuned FLAN-T5 model for personalized treatment generation, followed by post-processing with RxNorm for antibiotic stewardship and drug-drug interaction (DDI) screening. CLIN-LLM achieves 98% accuracy and F1 score, outperforming ClinicalBERT by 7.1% (p < 0.001), with 78% top-5 retrieval precision and a clinician-rated validity of 4.2 out of 5. Unsafe antibiotic suggestions are reduced by 67% compared to GPT-5. These results demonstrate CLIN-LLM's robustness, interpretability, and clinical safety alignment. The proposed system provides a deployable, human-in-the-loop decision support framework for resource-limited healthcare environments. Future work includes integrating imaging and lab data, multilingual extensions, and clinical trial validation.

Multimodal representation learning seeks to create a unified representation space by integrating diverse data modalities to improve multimodal understanding. Traditional methods often depend on pairwise contrastive learning, which relies on a predefined anchor modality, restricting alignment across all modalities. Recent advances have investigated the simultaneous alignment of multiple modalities, yet several challenges remain, such as limitations imposed by fixed anchor points and instability arising from optimizing the product of singular values. To address the challenges, in this paper, we propose Principled Multimodal Representation Learning (PMRL), a novel framework that achieves simultaneous alignment of multiple modalities without anchor dependency in a more stable manner. Specifically, grounded in the theoretical insight that full alignment corresponds to a rank-1 Gram matrix, PMRL optimizes the dominant singular value of the representation matrix to align modalities along a shared leading direction. We propose a softmax-based loss function that treats singular values as logits to prioritize the largest singular value. Besides, instance-wise contrastive regularization on the leading eigenvectors maintains inter-instance separability and prevents representation collapse. Extensive experiments across diverse tasks demonstrate PMRL's superiority compared to baseline methods. The source code will be publicly available.

This research discusses the critical need for early detection and treatment for early prediction of Freezing of Gaits (FOG) utilizing a wearable sensor technology powered with LoRa communication. The system consisted of an Esp-32 microcontroller, in which the trained model is utilized utilizing the Micromlgen Python library. The research investigates accurate FOG classification based on pertinent clinical data by utilizing machine learning (ML) algorithms like Catboost, XGBoost, and Extra Tree classifiers. The XGBoost could classify with approximately 97% accuracy, along with 96% for the catboost and 90% for the Extra Trees Classifier model. The SHAP analysis interpretability shows that GYR SI degree is the most affecting factor in the prediction of the diseases. These results show the possibility of monitoring and identifying the affected person with tracking location on GPS and providing aid as an assistive technology for aiding the affected. The developed sensor-based technology has great potential for real-world problem solving in the field of healthcare and biomedical technology enhancements.

Out-of-distribution (OOD) detection is crucial for ensuring the reliability and safety of machine learning models in real-world applications, where they frequently face data distributions unseen during training. Despite progress, existing methods are often vulnerable to spurious correlations that mislead models and compromise robustness. To address this, we propose SPROD, a novel prototype-based OOD detection approach that explicitly addresses the challenge posed by unknown spurious correlations. Our post-hoc method refines class prototypes to mitigate bias from spurious features without additional data or hyperparameter tuning, and is broadly applicable across diverse backbones and OOD detection settings. We conduct a comprehensive spurious correlation OOD detection benchmarking, comparing our method against existing approaches and demonstrating its superior performance across challenging OOD datasets, such as CelebA, Waterbirds, UrbanCars, Spurious Imagenet, and the newly introduced Animals MetaCoCo. On average, SPROD improves AUROC by 4.8% and FPR@95 by 9.4% over the second best.

This position paper argues that post-deployment monitoring in clinical AI is underdeveloped and proposes statistically valid and label-efficient testing frameworks as a principled foundation for ensuring reliability and safety in real-world deployment. A recent review found that only 9% of FDA-registered AI-based healthcare tools include a post-deployment surveillance plan. Existing monitoring approaches are often manual, sporadic, and reactive, making them ill-suited for the dynamic environments in which clinical models operate. We contend that post-deployment monitoring should be grounded in label-efficient and statistically valid testing frameworks, offering a principled alternative to current practices. We use the term "statistically valid" to refer to methods that provide explicit guarantees on error rates (e.g., Type I/II error), enable formal inference under pre-defined assumptions, and support reproducibility--features that align with regulatory requirements. Specifically, we propose that the detection of changes in the data and model performance degradation should be framed as distinct statistical hypothesis testing problems. Grounding monitoring in statistical rigor ensures a reproducible and scientifically sound basis for maintaining the reliability of clinical AI systems. Importantly, it also opens new research directions for the technical community--spanning theory, methods, and tools for statistically principled detection, attribution, and mitigation of post-deployment model failures in real-world settings.

Algorithmic fairness has emerged as a central issue in ML, and it has become standard practice to adjust ML algorithms so that they will satisfy fairness requirements such as Equal Opportunity. In this paper we consider the effects of adopting such fair classifiers on the overall level of ecosystem fairness. Specifically, we introduce the study of fairness with competing firms, and demonstrate the failure of fair classifiers in yielding fair ecosystems. Our results quantify the loss of fairness in systems, under a variety of conditions, based on classifiers' correlation and the level of their data overlap. We show that even if competing classifiers are individually fair, the ecosystem's outcome may be unfair; and that adjusting biased algorithms to improve their individual fairness may lead to an overall decline in ecosystem fairness. In addition to these theoretical results, we also provide supporting experimental evidence. Together, our model and results provide a novel and essential call for action.

The advent of single-cell Assay for Transposase-Accessible Chromatin using sequencing (scATAC-seq) offers an innovative perspective for deciphering regulatory mechanisms by assembling a vast repository of single-cell chromatin accessibility data. While foundation models have achieved significant success in single-cell transcriptomics, there is currently no foundation model for scATAC-seq that supports zero-shot high-quality cell identification and comprehensive multi-omics analysis simultaneously. Key challenges lie in the high dimensionality and sparsity of scATAC-seq data, as well as the lack of a standardized schema for representing open chromatin regions (OCRs). Here, we present ChromFound, a foundation model tailored for scATAC-seq. ChromFound utilizes a hybrid architecture and genome-aware tokenization to effectively capture genome-wide long contexts and regulatory signals from dynamic chromatin landscapes. Pretrained on 1.97 million cells from 30 tissues and 6 disease conditions, ChromFound demonstrates broad applicability across 6 diverse tasks. Notably, it achieves robust zero-shot performance in generating universal cell representations and exhibits excellent transferability in cell type annotation and cross-omics prediction. By uncovering enhancer-gene links undetected by existing computational methods, ChromFound offers a promising framework for understanding disease risk variants in the noncoding genome.